Surmodics Inc reports results for the quarter ended December 31 - Earnings Summary

SurModics

30/01/2025 15:06

* Surmodics Inc  SRDX.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported breakeven
earnings per share.  The mean expectation of three analysts for
the quarter was for a loss of 12 cents per share. Wall Street
expected results to range from -18 cents to -6 cents per share.
    * Revenue fell 2.1% to $29.92 million from a year ago;
analysts
expected $33.37 million. 
    * Surmodics Inc's reported EPS for the quarter was a loss
of 26
cents​.
    * The company reported a quarterly loss of $3.65 million.
    * Surmodics Inc shares had fallen by 9.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Surmodics Inc is
$43.00 
This summary was machine generated from LSEG data January 30 at
03:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.12          -0.04          Beat
 Sep. 30 2024      -0.29          -0.13          Beat
 Jun. 30 2024      -0.33          -0.27          Beat
 Mar. 31 2024      -0.32          0.07           Beat